ReviewCurrent opinion in molecular therapeutics2007
Recent advances in neuroproteomics.
Review in Current opinion in molecular therapeutics, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Proteomic analysis of human frontal and temporal cortex using iTRAQ-based 2D LC-MS/MS.Chinese neurosurgical journal · 2021Article
- Proteomic comparison of different synaptosome preparation procedures.Amino acids · 2020Article
- From Synapse to Function: A Perspective on the Role of Neuroproteomics in Elucidating Mechanisms of Drug Addiction.Proteomes · 2018Review
- Recent advances in quantitative neuroproteomics.Methods (San Diego, Calif.) · 2013Review
- Quantitative neuroproteomics: classical and novel tools for studying neural differentiation and function.Stem cell reviews and reports · 2011Review
- Proteomic studies on the development of the central nervous system and beyond.Neurochemical research · 2010Review
- Proteomic analysis of an alpha7 nicotinic acetylcholine receptor interactome.Journal of proteome research · 2009Article
- Mass spectrometry-based proteomics and peptidomics for biomarker discovery in neurodegenerative diseases.International journal of clinical and experimental pathology · 2009Article
- Protein expression in the nucleus accumbens of rats exposed to developmental vitamin D deficiency.PloS one · 2008Article
- Genomic and Proteomic Biomarker Discovery in Neurological Disease.Biomarker insights · 2008Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The last few years have seen a rapid growth in the use of proteomic methods to study normal brain function. In addition, such methods have been used to analyze changes in protein expression associated with the onset and progression of neuronal disease. The field of neuroproteomics faces special challenges given the complex cellular and sub-cellular architecture of the central nervous system. This article presents a review of recent progress in studies of neuroproteomics, and highlights the strengths and limitations of current proteomic profiling technologies used in studies of neuronal protein expression.
Indexed as
Identifiers
17608026PMC3373961What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.